Advertisement

Lymphoma Affecting the Central Nervous System

  • Barbara Pro
Part of the M. D. Anderson Cancer Care Series book series (MDCCS)

Keywords

Cerebral Spinal Fluid Primary Central Nervous System Lymphoma Radiation Therapy Oncology Group Intrathecal Chemotherapy Median Survival Duration 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abrey LE, Moskowitz CH, Mason WP, et al. Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis. J Clin Oncol 2003;21:4151–4156.PubMedCrossRefGoogle Scholar
  2. Abrey LE, Yahalom J, DeAngelis LM. Treatment for primary CNS lymphoma: the next step. J Clin Oncol 2000;18:3144–3150.PubMedGoogle Scholar
  3. Auperin J, Mikolt J, Oksenhendler E, et al. Primary central nervous system malignant non-Hodgkin's lymphomas from HIV-infected and non-infected patients: expression of cellular surface proteins and Epstein-Barr viral markers. Neuropathol Appl Neurobiol 1994;20:243–252.PubMedCrossRefGoogle Scholar
  4. Bataille B, Delwail V, Menet E, et al. Primary intracerebral malignant lymphoma: report of 248 cases. J Neurosurg 2000;92:261–266.PubMedCrossRefGoogle Scholar
  5. Cheng T, Forsyth P, Chaudhry A, et al. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy in primary CNS lymphoma. Bone Marrow Transplant 2003;31:679–685.PubMedCrossRefGoogle Scholar
  6. Corboy JR, Garl PJ, Kleinschmidt-DeMasters BK. Human herpes-virus 8 DNA in CNS lymphomas from patients with and without AIDS. Neurology 1998;48:1333–1335.Google Scholar
  7. DeAngelis LM, Yahalom J, Thaler HAT, Kher U. Combined modality therapy for primary central nervous system lymphoma. J Clin Oncol 1992;10:635–643.PubMedGoogle Scholar
  8. Enting RH, Demopoulos A, DeAngelis LM, Abrey LE. Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology 2004;63:901–903.PubMedGoogle Scholar
  9. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993;119:1093–1104.PubMedGoogle Scholar
  10. Glass J, Gruber ML, Cher L, Hochberg F. Preirradiation methotrexate chemotherapy of primary central nervous system lymphoma: long-term outcome. J Neurosurg 1994;81:188–195.PubMedCrossRefGoogle Scholar
  11. Guha-Thakurta N, Damek D, Polack C, Hochberg FH. Intravenous methotrexate as initial treatment for primary central nervous system lymphoma. Response to therapy and quality of life of patients. J Neurooncol 1999;43:259–268.PubMedCrossRefGoogle Scholar
  12. Herrlinger U, Brugger W, Bamberg M, Kuker W, Dichgans J, Weller M. PVC salvage chemotherapy for recurrent primary CNS lymphoma. Neurology 2000;54: 1707–1708.PubMedGoogle Scholar
  13. Lachance DH, Brizel DM, Gockerman JP, et al. Cyclophosphamide, doxorubicin, vincristine and prednisone for primary central nervous system lymphoma: short duration of response and multifocal intracerebral recurrence preceding radiotherapy. Neurology 1994;44:1721–1727.PubMedGoogle Scholar
  14. Nelson DF, Martz KL, Bonner H, et al. Non-Hodgkin's lymphoma of the brain: can high dose, large volume radiation improve survival? Report on a prospective trial by the Radiation Therapy Oncology Group (RTOG): RTOG 8315. Int J Radiat Oncol Biol Phys 1992;23:9–17.PubMedGoogle Scholar
  15. Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS. Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol 2005;23:1507–1513.PubMedCrossRefGoogle Scholar
  16. Schultz H, Pels H, Schmidt-Wolf I, Zeelen U, Germing U, Engert A. Intraventricular treatment of relapsed central nervous lymphoma with the anti-CD20 antibody rituximab. Haematologica 2004;89:753–754.Google Scholar
  17. Schultz C, Scott C, Sherman W, et al. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of Radiation Therapy Oncology Group protocol 88–06. J Clin Oncol 1996;14:556–564.PubMedGoogle Scholar
  18. Soussain C, Suzan F, Hoang-Xuan K, et al. Results of intensive chemotherapy followed by hematopoietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J Clin Oncol 2001;19:742–749.PubMedGoogle Scholar
  19. Wong ET, Tishler R, Barron L, Wu JK. Immunochemotherapy with rituximab and temozolomide for central nervous system lymphomas. Cancer 2004;101: 139–145.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Barbara Pro

There are no affiliations available

Personalised recommendations